Intestinal Microflora: Metabolism of Drugs and Carcinogens
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The intestinal microflora are capable of performing a wide variety of metabolic transformations. The digestive tract can be exposed to orally ingested, bile excreted, or blood-borne exogenous and endogenous substances that can be converted by the intestinal flora into carcinogens, mutagens, cocarcinogens or tumor promoting agents. In addition, the intestinal microflora can metabolize a wide variety of pharmacological agents resulting in production of metabolites required for the physiological activity of these agents or conversely in the inactivation of these agents. This article reviews the current knowledge of the relationship between the intestinal microflora and the metabolic reactions leading to the transformation of drugs and the production of mutagenic or carcinogenic compounds. The composition and distribution of bacteria in the gastrointestinal tract is discussed and the type of reactions these bacteria perform is summarized. The conversion of specific substrates such as, rutin, digoxin, cycasin, azulfidine and cyclamate are discussed and the physiological implication of these conversions are presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human Fecal Flora: The Normal Flora of 20 Japanese-Hawaiians
Moore, W. E. C., & Holdeman, L. V. (1974) · Applied Microbiology · doi:10.1128/am.27.5.961-979.1974 · Cited by 1,144
THE ROLE OF INTESTINAL BACTERIA IN THE METABOLISM OF SALICYLAZOSULFAPYRIDINE
PEPPERCORN, M. A., & GOLDMAN, P. (1972) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29238-2 · Cited by 450
Inactivation of Digoxin by the Gut Flora: Reversal by Antibiotic Therapy
Lindenbaum, J., Rund, D. G., Butler, V. P., Tse-Eng, D., & Saha, J. R. (1981) · New England Journal of Medicine · doi:10.1056/nejm198110013051403 · Cited by 423
Fecalase: a model for activation of dietary glycosides to mutagens by intestinal flora
Tamura, G., Gold, C., Ferro-Luzzi, A., & Ames, B. N. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.8.4961 · Cited by 182
Cited by
The Role of Probiotic Cultures in the Control of Gastrointestinal Health
Rolfe, R. D. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.2.396s · Cited by 925
Review article: bifidobacteria as probiotic agents – physiological effects and clinical benefits
PICARD, C., FIORAMONTI, J., FRANCOIS, A., ROBINSON, T., NEANT, F., & MATUCHANSKY, C. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02615.x · Cited by 618
Kleessen, B., Sykura, B., Zunft, H., & Blaut, M. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1397 · Cited by 585
Survival ofLactobacillus species (strain GG) in human gastrointestinal tract
Goldin, B. R., Gorbach, S. L., Saxelin, M., Barakat, S., Gualtieri, L., & Salminen, S. (1992) · Digestive Diseases and Sciences · doi:10.1007/bf01308354 · Cited by 554
Self-citationProbiotics, their health benefits and applications for developing healthier foods: a review
Nagpal, R., Kumar, A., Kumar, M., Behare, P. V., Jain, S., & Yadav, H. (2012) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2012.02593.x · Cited by 489
Metadata
- Authors
- Goldin, B. R.
- Venue
- Annals of Medicine
- Publisher
- Informa UK Limited
- Published
- 1990-01
- Volume
- 22
- Issue
- 1
- Pages
- 43-48
- ISSN
- 0785-3890 (ISSN-L)
- 1365-2060
- OpenAlex
- W2060997715
- Cited by
- 143
- References
- 4
- FWCI
- 0.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.